Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06458049 · ClinicalTrials.gov registry record · NA

Sexual Health and Rehabilitation Online (SHAREonline)

A NA study of Cancer Survivorship and Sexual Function Disturbances, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT06458049: Active NA study of Cancer Survivorship and Sexual Function Disturbances, sponsored by Dana-Farber Cancer Institute.

NCT06458049 is a NA study of Cancer Survivorship and Sexual Function Disturbances that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 84 participants, below the 253-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06458049, a NA study of Cancer Survivorship and Sexual Function Disturbances, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

SHAREonline is a study for young female cancer survivors that are experiencing changes in sexual health and function. The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual health and functioning.

Primary Outcome

The Female Sexual Function Index (FSFI Full Scale Score), is 19-item instrument which measures sexual function, including desire, orgasm, pain and satisfaction.

Interventions

  • BEHAVIORAL Educational Materials
  • BEHAVIORAL Group Session
  • BEHAVIORAL Coaching Call

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2025-02-19
Est. Completion 2027-05-31
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the registry record for NCT06458049 still lists

NCT06458049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 253-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (67% lower).

The record links to 2 conditions, with Cancer Survivorship appearing as the primary indexed condition, and to 3 interventions - of which Educational Materials is the first listed.

NCT06458049 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06458049 about?

NCT06458049 is a clinical study titled "Sexual Health and Rehabilitation Online (SHAREonline)". SHAREonline is a study for young female cancer survivors that are experiencing changes in sexual health and function. The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual healt...

What is the current status of trial NCT06458049?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2025-02-19. Estimated completion is 2027-05-31.

What conditions does trial NCT06458049 study?

This clinical trial studies the following conditions: Cancer Survivorship, Sexual Function Disturbances.

What interventions are being tested in trial NCT06458049?

The interventions under investigation include: Educational Materials (BEHAVIORAL), Group Session (BEHAVIORAL), Coaching Call (BEHAVIORAL).

Who is sponsoring clinical trial NCT06458049?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06458049 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivorship

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06458049's enrollment target sits among peer trials

84 6th of 11 higher than 6 of 11 other Cancer Survivorship trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer Survivorship trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06458049, the US trial registry maintained by the National Library of Medicine. NCT06458049 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.